Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells

BACKGROUND: Drug resistance remains as a challenge in the treatment of HER2-overexpressed breast cancer. Emerging evidence from clinical studies show relation of oxidized low density lipoprotein (LDL) and very low density lipoprotein (VLDL) level with drug resistance. However, the underlying molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Siti, Z.S., Seoparjoo, A.M.I., Shahrul, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488741/
https://www.ncbi.nlm.nih.gov/pubmed/31183434
http://dx.doi.org/10.1016/j.heliyon.2019.e01573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488741/
https://www.ncbi.nlm.nih.gov/pubmed/31183434
http://dx.doi.org/10.1016/j.heliyon.2019.e01573

Ejemplares similares